Glaucoma remains only partially understood, particularly at the level of intraocular pressure
(IOP) regulation. Trabecular meshwork (TM) and Schlemm's canal inner wall endothelium …

The burden of irreversible vision loss from Glaucoma continues to rise. While the disease
pathogenesis is not well understood, intraocular pressure (IOP) is the only modifiable risk …

Trabecular meshwork (TM) cell dysfunction is the leading cause of elevated intraocular
pressure (IOP) and glaucoma. The long non‐coding RNA (lncRNA) small nucleolar RNA …

Glaucoma is identified by the loss of retinal ganglion cells (RGCs). The primary approach to
managing glaucoma is to control intraocular pressure (IOP). Lately, there has been an …

The trabecular meshwork (TM) is composed of TM cells and beams of the extracellular
matrix, together contributing to aqueous humor (AH) outflow resistance. Herein, we validated …

Background/Objectives: Mammalian target of rapamycin (mTOR) inhibition may have been
suggested to have a beneficial effect on the glaucomatous human trabecular meshwork …

Background: Various cell culture platforms that could display native environmental cue-
mimicking stimuli were developed, and effects of environmental cues on cell behaviors were …

Glaucoma, a blind‐leading disease largely since chronic pathological intraocular high
pressure (ph‐IOP). Hitherto, it is reckoned incurable for irreversible neural damage and …

We report herein on the effects of all-trans retinoic acid (ATRA) on two-dimensional (2D) and
three-dimensional (3D) cultures of human trabecular meshwork (HTM) cells that were …

High intraocular pressure (IOP) is a recognized risk factor for glaucoma and optic nerve
injury, and it is one of the primary causes of vision loss globally. Anabasis articulata (AA) is a …